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Abstract: 
The amyloid formation of the folded segment of a variant of Exenatide (a marketed drug for Type-2 
Diabetes Mellitus) was studied by ECD and NMR. We found that the optimum temperature for E5 
amyloidosis coincides with body temperature and requires well below physiological salt concentration. 
Decomposition of the ECD spectra and its barycentric representation on the folded-unfolded-amyloid 
potential energy surface allowed us to monitor the full range of molecular transformation of 
amyloidogenesis. We identified points of no return (e.g. T=37°C, pH=4.1, cE5=250µM, cNaCl=50mM, t>4-6 
h) which will inevitably gravitate into the amyloid-state. The strong B-type FUV-ECD spectra and an 
unexpectedly strong NUV-ECD signal (Θ~275-285nm) indicate that the amyloid phase of E5 is built from 
monomers of quasi-elongated backbone structure (φ~-145°, ψ~+145°) with strong interstrand Tyr↔Trp 
interaction. Misfolded intermediers and the buildup of “toxic” early-stage oligomers leading to self-
association were identified and monitored as function of time. Results indicate that the amyloid 
transition is triggered by subtle misfolding of the α-helix exposing aromatic and hydrophobic side-chains 
that may provide the first centers for an intermolecular reorganization. These initial clusters provide the 
spatial closeness and sufficient time for a transition to the β-structured amyloid nucleus thus the process 
follows a nucleated growth mechanism.   
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Abbreviations: 
 
AMBER, Assisted Model Building with Energy Refinement, Amy-state, amyloid state; APP, Amyloid 
precursor protein; ARIA, Ambiguous Restraints for Iterative Assignment; Aβ(1-42), beta-amyloid peptide 
(1-42); Aβ2M, amyloidogenic β2-microglobulin; CNS, central nervous system; CryoEM, Cryo-electron 
microscopy; DLS, Dynamic light scattering; ECD, Electronic Circular Dichroism; Ex-4, Exendin-4; F-state, 
folded state; FT-IR, Fourier-transform infrared spectroscopy; FUV-ECD, far ultraviolet electronic circular 
dichroism: 185-260 nm; GLP-1R, Glucagon-like peptide-1 receptor; GROMACS, GROningen MAchine for 
Chemical Simulations, Hanabi, HANdai Amyloid Burst Inducer; HSQC, Heteronuclear single quantum 
coherence; I-state, intermediate state; MD simulation, Molecular Dynamics; NMR, Nuclear magnetic 
resonance; NOE, Nuclear Overhauser effect; NOESY, Nuclear Overhauser Effect SpectroscopY; NUV-ECD, 
near ultraviolet electronic circular dichroism: 260-325 nm;  Pro-IAPP, pro-islet amyloid polypeptide 
RMSD, backbone all atoms root-mean standard deviation in Ångstroms,  s/n, signal to noise ratio; SAXS, 
Small-angle X-ray scattering; SS-bond, disulfide bond; ssNMR, Solid-state nuclear magnetic resonance; 
T2DM, Type-2 Diabetes Mellitus; TOCSY, Total Correlated SpectroscopY, Trp-cage, tryptophan- cage; U-
state, unfolded state;  
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Introduction: 
Aggregation of proteins and peptide segments into amyloid fibrils have been studied intensively 
over the past decades since the process was shown to be associated with, or even trigger (1-3) such 
illnesses as Alzheimer’s disease, type II Diabetes Mellitus, Rheumatoid arthritis, or Haemodialysis ass. 
amyloidosis (4). From the pioneering work on lysozyme (5) and Aβ(1-42) (6-8), the amyloid state of 
several misfolded proteins (e.g. β2-microglobulin (9), crystalline (10), tau protein (11-13), the glucagon 
peptide hormone (14) and insulin (15) among others) were characterized. The general topology of such 
aggregates consists of protein segments adopting an extended backbone, interacting through β-edges. 
The association between the β-sheets thus formed is compact and specific, in most cases it excludes 
water molecules, leading to the formation of tightly stacked, “dry-zipper” nanostructures (16-18). The 
state-of-the-art TEM, SAXS, cryo-EM and ssNMR techniques now allow the full characterization of the 
aggregated end-state (19-20), however, much less is known about the specific molecular species that 
evolve during the process, especially in the early stages which concern the formation of still soluble but 
oligomeric assemblies that are the most toxic (1-3, 21-22) and also represent the stage where 
amyloidosis can still be reversed (23). 
The progress of self-association can often be followed by ThT fluorescence and DLS – best in 
combination (24) - reporting the accumulation of cross--backbone (above a minimum size of 
approximately 10 nm or 4-6 aligned strands (25)) and the size distribution of the species present in the 
solution, respectively. However, to gain atomistic detail, molecular spectroscopies need to be applied 
such as CD, IR or NMR (26, 27). In fact, CD spectroscopy can be used to monitor a full range of molecular 
transformation accompanying amyloidogenesis if the secondary structure contents of the folded, 
intermediate and amyloid states are distinct. There are notable examples that satisfy that description, 
namely helical peptide hormones like amylin or glucagon and a considerable number of peptide 
therapeutics (28) and since over 60% of all protein-protein interfaces - typical targets of drug design – 
also constitute helices (29), their number will most likely just increase.  
Here we present the amyloid formation pathway of a variant of Exenatide, a marketed drug for 
Type-2 Diabetes Mellitus (30) that also contains a well-folded -helix. We have discovered that this 25 
residue long segment (E5: EEEAVRLYIQWLKEGGPSSGRPPPS) (Figure 1), comprising of the entire interface 
needed for GLP-1 receptor binding (31), can be turned into amyloid in a controlled, fully reproducible 
and tunable manner within a large range of protein concentrations (80µM < cprot.< 800µM) at 
physiologically relevant temperatures. Therefore, understanding the molecular details of the amyloidosis 
of E5 and mapping its conditions is highly relevant to any optimization efforts targeting Exenatide. In 
addition, E5 is an ideal model to study the amyloid transition of folded proteins and helix-containing 
peptides. Beside its helical stretch, E5 contains a -turn, a polyproline-II helix and a hydrophobic center 
with a buried Trp, thus has a protein like build-up and also folds quite similarly to a typical globular 
protein (32). As E5 is small, both its chemical synthesis on a resin and bacterial expression in a fusion 
system is straightforward (33). Because its folded state is partially helical, its transition toward the 
amyloid phase results in a significant change in secondary structure content, easy to monitor by CD 
spectroscopy. Furthermore, E5 has an interacting Trp/Tyr residue pair within its hydrophobic core, 
enabling to track folding and refolding of the protein by NUV- beside FUV-CD. We also found the process 
to be quenchable; by dropping the temperature the amyloid formation can be suspended at any time 
4 
 
and restarted by a subsequent temperature rise. Also, the moderate size of E5 allows detailed structure 
characterization both by NMR and modeling techniques.  
 
 
Figure 1. A) The primary sequence of E5 with residues colored by their charges of pH=7: negatively charged amino 
acid, positively charged amino acid and neutral amino acid are highlighted with red, blue and dark grey, 
respectively. B) The overall charge (z) of E5 as a function of the pH calculated by Prot pi (www.protpi.ch) C) The 
solubility of E5 as a function of the pH (at 25°C) shows that near the isoelectric point reversible precipitation occurs. 
D) The folded structure of E5 (4°C & pH=7) determined by NMR, with its 4 basic groups (highlighted blue), and 5 
acidic groups (highlighted red) with the following pKa values: SerC-terminal: pKa:2.2, Glusidechain:pKa:4.3, GluN-terminal: 
pKa:9.1, Lyssidechain: pKa:10.8 and Argsidechain: pKa:12.5. E) The major microstates with their labeling are depicted 
schematically at 4 different pHs of interest, with side-chain colored by charge: neutral-black, negative-red and 
positive-blue, respectively. 
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We probed various regions of the f(T, pH, cprot, cion, t) potential energy hypersurface of E5 by 
acquiring quantitative NUV- and FUV-ECD chiroptical information and NMR data complemented by MD 
simulations to pinpoint the reaction path that leads from the fully folded- to the amyloid-state. Based on 
these results we were able to propose a mechanism that though resembles that of well-folded proteins’ 
but relies on special features of the miniprotein. The methodology presented here gains significance as 
the amyloid state of E5 is ThT silent and thus presents an approach for dealing with such cases as well. 
 
Results and Discussion:  
We have shown previously (Farkas Eur J Org Chem 2013) that high concentrations (c~10-30 mM) 
of E5 trigger self-association, accompanied by an α-helix to antiparallel β-sheet structural transition. 
Here we set out the way to identify optimum conditions of aggregation structurally characterizing key 
states along this route at a physiologically more relevant concentration range using NMR, NUV- and FUV-
ECD data to pinpoint misfolded structures of the reaction path, and electron-microscopy to confirm the 
emerging amyloid fibrils.  
 
  
Figure 2. TEM images of E5 amyloid fibrils. Typical twisted amyloid fibrils were observed. Most 
fibrils were bundled and formed supercoiled structure. Scale bars indicate 500 nm. 
 
To locate roughly and effectively those conditions that enable the amyloid formation, the 
HANABI system (Umemoto et al., 2014, JBC, 289, 27290-27299) was applied. The 96 well plates were set 
up with the following boundaries: 2< pH< 7, 80 µM< cE5< 800 µM and 0 mM< cNaCl< 100 mM at T= 37 °C. 
ECD measurements were carried out after 90 h, with sonication cycle turned „on” for 1 min and 
repeated every 10 minutes (power level: 700 W and frequency: 25 kHz). FUV-ECD measurements 
showed that amyloid formation is more effective in the presence than in the absence of salt (cNaCl=100 
mM), with the preferred protein concentration ranging from 80 to 160 µM, while the optimal pH is near 
4.0. The amyloid thus produced showed a typical twisted fibril structure (Figure 2). The formation of 
these fibrils could not be followed by ThT fluorescence and thus ECD-spectra were recorded for each of 
the 96 wells. Based on the results additional experiments were designed to identify parameters of 
amyloid formation separately, to pinpoint their significance and specific molecular consequences.  
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Optimum conditions located for E5 amyloid formation: the temperature-scan 
NMR (2D Homonuclear) measurements were carried out to determine the structure of E5 at each of 
the following temperatures: 4, 15, 26, 37 and 48°C (@ pH= 7, cprot= ~0.8mM, cion= ~0 mM) leading to the 
primary conclusion that as temperature increases partial unfolding occurs without amyloid formation. 
We found that though NMR-resonance frequencies shift with rising T, line broadening only takes place 
above 37°C, indicating considerable unfolding only at 48°C (SFigure 1). The unsynchronized local 
backbone fluctuation of the folded F-state enhances as T increases. Furthermore, we have determined 
the most T-sensitive residues of E5 for which the presence of hidden intermediate(s) (I-state(s)) (Rovo 
et.al. ChemEur J 2013, Rovo et al. Bichemistry 2014) was revealed. The thermal unfolding of the protein 
backbone shows a non-linear T-dependence for Leu7, Ile9, and Lys13 and to a lesser extent for Ala4, Val5 
and Tyr8, indicating an enhanced presence of transient conformers at higher temperatures for the inner 
helix of E5. (Figure 1, SFigure 2). 3D-structure elucidations were also completed by acquiring a large 
number of NOE distance-restrains (Figure 3 and STable 1) at all temperatures of interest. Although the 
total number of restrains drops as T increases, 666 (4°C) → 221 (48°C), the latter number of NOEs are 
still sufficient to establish the overall 3D-fold of E5 even at 48°C (especially since 16 out of 221 are key 
long-range restraints) (Figure 3/E and STable 1). Inter-residue NOEs associated with Y8 and W11 (SFigure 
3) enabled us not only to determine the overall molecular scaffold but also the relative orientation of the 
two aromatic side chains. At 37°C, 458 distance restraints in total, among which 40 long range ones 
(i→(i+<5)) were assigned, enables to get a single time-average and compact 3D-structure for E5. While 
the central α-helix is tightly folded at this temperature (RMSD of the backbone heavy atoms is 0.64 Å 
within the 50 best-fit structures), (STable 1) as T increases the unfolding of the -P17SSGRP22- segment was 
detected. This segment is the least structured bit within the folded scaffold even at 4°C, where only 
sequential NOEs could be measured (Figure 3/C). Nevertheless, the large number of NOEs associated 
with Y8 and W11 residues and the -P22PP24- segment ensures their concerted motion, signaling that the 
hydrophobic core remains well-structured at 37 °C and below (SFigure 3).  
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Figure 3 A) Superimposed best 50 NMR 
structures of E5 at different pHs and 
temperatures (conditions and the net charges 
explicitly shown for each structure ensemble). 
The background color indicates the fold 
compactness: green - unfolded, grey - folded, 
red – misfolded leading to amyloid formation. 
Aromatic side chains of the key Y8 and W11 
are highlighted magenta. The basic (N-term., 
6R, 13K, 21R) moieties are protonated, the C-
terminus (25S) deprotonated, while the 
protonation microstates of Glu residues are 
shown at the right side at each pH. All atoms 
backbone RMSD (Å) as a function of the 
primary sequence of E5 at B) different 
temperatures (°C) and C) different pHs are 
plotted. The total number of NOEs assigned 
for E5: ΣNOEi→(i+1), ΣNOEi→(i+k) where k= 2,3,4, 
ΣNOEi→(i+5<) are reported as D) the 
temperature was scanned at pH=6.9 and E) as 
pH scanned at T=15°C. 
 
Due to exchange phenomena, NMR is 
unable to provide precise structural 
information at high T, therefore 
complementary FUV-ECD measurements 
were carried out to follow the transition 
of the backbone fold up to 85 °C. The 
recorded spectra were deconvoluted 
using the CCA+ protocol as mixtures of 
folded (F-) and unfolded (U-) forms (ref 
Perczel 1991 ProtEng, Perczel 1992 
ProtStructfunc Gen, Jakli 2009, JPeptSci). 
At lower temperatures, in line with the 
NMR data, the folded fraction is 
dominant (F content goes from 100 to 
80% as T increases from 5°C to 35 °C), a 
50-50% mixture is reached near 60 °C, 
while at 85°C the spectrum indicates a 
70% unfolded content (SFigure 4).  
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The pH-scan  
2D-NOESY driven 3D-structure elucidation was completed (cE5~ 500-1500 µM, cNaCl< 10 mM) at 
various pHs: 6.9, 5.9, 5.0, 4.1, 2.0 at T= 15°C (Figure 3/B). (The poorer signal to noise ratio required 
longer measurement time at pH= 5.0 and 4.1.) The solubility of E5 drops close to its isoelectric point 
(pH=4.8, Figure 1) where unspecific and reversible precipitation was observed. As side chain protonation 
pattern varies with pH, H-bonds and other weak interactions change as well. E5 contains a protonated N-
terminal (pKa= 9.1) plus 3 basic residues, Arg6 (pKa= 12.5), Lys13 (pKa= 10.8) and Arg21 (pKa= 12.5), with an 
acidic C-terminal (pKa= 2.2) and 4 acidic glutamines (Glu1, Glu2, Glu3 and Glu14) (pKa~ 4.25). (The listed 
pKa-s are nominal values that strongly depend on backbone conformation). The net charge of E5 is 
predicted to be positive at pHs smaller than 5 (Figure 1). At pH=7.0 two salt bridges may contribute to 
the stabilization the 3D-fold, those of Glu1(-)↔Arg6(+) and Glu14(-)↔Arg21(+). But as pH decreases, 
Glu(s) get partly (or completely) protonated and thus salt bridges weaken and 3D-fold compactness 
loosens. Accordingly, at pH=6.9, 5.9 and 5.0 the measured 3D-structures of E5 are similar (Figure 3), 
although conformational heterogeneity increases considerably (demonstrated by the reduction of the 
total number of assigned restrains from 666 to 319 (Figure 3/F and STable 1)). Thus, the Trp-cage fold 
holds, though backbone heavy atom RMSD of the 50 best structures increases significantly: RMSD 
pH=6.9,T=15°C= 0.73 Å → RMSD pH=5.0,T=15°C= 2.56 Å (STable 1). We found that the total number of NOESY 
cross-peaks between R21 and W11 residues is a reliable measure of the Trp-cage fold compactness 
(SFigure 3): 11 and 10 such peaks were assigned at pH=6.9 and 2.0, but only 3 at 5>pH>4 (T=15°C). 
Moreover, RMSD changes show that the α-helix becomes partly unfolded, as the pH gets closer to 4.1 
(Figure 3/D). The structure loosening effect of the pH drop is the most pronounced between residue 13 
and 21: the 310-helix (-G15GPSSG20-) tends to unwind, exposing both the Y8 and W11 core residues to 
external water molecules (Figure 3). Interestingly enough, moving beyond the isoelectric point, ordering 
of the ensembles takes place and the original F-state reappeared at pH=2. At pH=6.9 77 long-range 
NOEi→(i+5) restraints were assigned, while at pH=2.0 in total 84 NOEsi→(i+5) were found. This is rather 
unexpected since the overall charge, as well as the local charge distribution of E5 is indeed different at 
the above two pHs. Meanwhile, in between, at pH= 4.9 only 22 NOEs of this kind were recorded (Figure 
3/B). In conclusion, the pH-scan shows that the basic topological features of the Trp-cage fold of E5 (and 
other analogs K.A.Graham et al. 2018) are preserved at pH= 7.0 and 2.0, but weakened near the 
isoelectric point, where I-states of full refolding potential or of amyloidogenic misfolding capacity could 
be present simultaneously (SFigure 5).  
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The effect of stirring  
At pH=4.1 and T=37 °C in the absence of stirring or sonication the gradual decay of the far-UV 
ECD spectrum intensities of E5 was detected, indicative of self-association leading to the loss of 
monomeric form or weakly bound low molecular weight associates in the solution (SFigure 6). Stirring 
however greatly speeds up visible precipitation, aiding both the nucleation and fibril maturation stages 
of amyloidogenesis. The former one is facilitated by the increasing number of collisions occurring 
between monomers and/or small oligomeric clusters and the later one by removing parts from the 
longer fibrils and thus initiating new nucleation sites (C-C. Lee Biophys. J. 2007, Serio, T. R. Science 2000). 
 
 
Figure 4: A) FUV-ECD spectra of E5 recorded after 51 h of incubation time at a constant stirring (cE5=250 µM, cNaCl= 
50 mM, T=37 °C). If ΣQE5pH=4.1= +2, then a B-type ECD is detected, which is indicative of a β-sheet backbone structure. 
However, if pH=7.0 (ΣQE5pH=7.0=-1) or pH=2.1 (ΣQE5pH=2.1=+4.0) E5 remains folded (predominantly α-helical B) Spectral 
deconvolution enables to determine the approximate [F] and [Amyloid] ratios as function of the net molecular 
charge: ΣQE5.  
 
Stirring the solution of E5 for 51h (pH=4.1) resulted in strong B-type FUV-ECD spectrum 
indicating a predominantly β-pleated sheet backbone structure (SREERAMA 1999, Micsonai 2015, PNAS). 
When setting the pH at 4.9, 4.4 and 3.0 “mixed” ECD spectra were recorded (B/C-type) even after 51 h 
(Figure 4) signaling that in solution both helical and β-stranded structures are present, amyloid 
formation is less complete. Furthermore, at pH=7 and pH=2 pure C-type ECD spectra were measured 
(even when stirring) indicating that only -helical backbone structures are in solution and thus, these 
pHs prevent amyloid formation. To quantify the extent of the transition from the folded toward the 
amyloid-like phase, deconvolution of a large collection ECD spectra were carried out (including E5 and E0 
T-dependent ECD curves). In this way we obtained 3 pure component spectra, which turned out to be 
the following: a C-type for -helical conformation, a U-type corresponding to the unstructured and a B-
type signaling -stranded backbone conformation. For E5 these 3 pure ECD curve types stand for i) the 
folded, ii) for the unfolded and iii) the amyloid states, respectively. More interestingly, a similar NUV-ECD 
spectrum analysis shows (see below) that this transition is more complex than a simple - to - 
backbone conformational shift. Complemented with dynamic light scattering measurement data we 
conclude that these NUV-ECD spectral changes are associated with a gradual amyloid formation.  
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The overall path from the F- to the amyloid state is reported using a barycentric coordinate 
system (Figure 4 and 5) in which the gradual maturation of the amyloid as a function of the time is 
visualized. At any point along the route, the ratio of the folded, unfolded and amyloid-states can be 
calculated from the deconvoluted spectral properties. As an example the “mixed state” of 
[pF(t=5h)=0.26, pU(t=5h)=0.50, pAmy(t=5h)=0.24] or simply (0.26, 0.5, 0.24) is shown on Figure 5 (see the 
“yellow dot” of Figure 5/D).  
Using this mapping technique three phases of the amyloid formation of E5 could be 
differentiated as i) initially the path runs parallel to the folded→unfolded axis, with no or marginal 
contribution of the amyloid state, corresponding to a misfolding phase, with the gradual accumulation of 
the unfolded/misfolded forms. ii) During the second phase the route turns and runs parallel to the folded 
→ amyloid axis, corresponding to the nucleation phase. During this phase a critical concentration of 
misfolded structures is reached: F-state diminishes while Amy-states start to accumulate, while the 
misfolded content remains nearly constant. iii) The third phase runs parallel to the unfolded→amyloid 
axis, where no further reversible unfolding takes place: the misfolded/unfolded structures get trapped 
by the growing amyloids: the elongation phase of the E5 amyloidosis.  
 
 
Figure 5: A) The C-type FUV ECD of E5 (F-state) gradually shifts as function of the time, as amyloid formation 
progresses (cE5=250µM, cNaCl= 50mM, pH=4.1, stirring at T=37°C). The final B-type spectrum stands for the amyloid 
state (t= 51 h) composed of β-strands. B) An ensemble of the FUV-ECD spectra of E5 forming amyloid (panel A) was 
formed with those of the T-dependent E0 (Rovó Biochem 2014) and E5 (5< T(°C)< 85) and deconvoluted into 3 pure 
component spectra (C) standing for the F-(black), U-(green)- and Amyloid-states (red). D) The CCA+ resulted in 
relative coefficients of these 3 pure ECD spectra depict the amyloid formation path in a Barycentric coordinate 
system: after 5 h ratio is 26% F-, 50% U- & 24% Amy-state (yellow dot) (c.f. SFigure 7). 
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Fine-tuning cprotein and csalt affecting the amyloid formation  
 
Although E5 can form amyloid at low salt (cNaCl <1 mM) and high protein concentrations (cE5 >5-
15 mM) (Farkas 2013), at these extreme conditions amyloid formation is poorly reproducible. To locate 
physiologically more relevant and controllable amyloidogenic conditions on the ΔG= f(T,pH,cprot,cion,t,) 
surface, both cE5 and cNaCl variables had to be optimized at a sensible concentration range: 250< cE5 < 800 
µM and 12.5 <cNaCl < 50 mM with T & pH set as: T =37°C & pH= 4.1. Fine-tuning was completed with the 
HANABI system in a concerted manner leading to the identification of several concentration pairs for 
which amyloid formed and the transition was reproducible, namely cE5=250 µM & cNaCl=50 mM, cE5=500 
µM & cNaCl=25 mM cE5=800 µM & cNaCl=12.5 mM (with the solution constantly stirred). Thus, if the protein 
concentration is higher, then even at a lower salt concentration amyloid formation was observed (Figure 
6 and SFigure 8).  
As protein concentration increases, amyloid formation becomes more complete: Amy]c(E5)=400uM 
(t= 8 h)= 0.34, [Amy]c(E5)=800mM(t= 8 h)= 0.61 even when salt concentration is low and fixed at cNaCl= 12.5 
mM (a condition more suitable for NMR) (Figure 7/a, SFigure 9).  
 
 
Figure 6: Amyloid forms at a large concentration range: from cE5=250 µM & cNaCl=50 mM up to cE5=800 µM & cNaCl = 
12.5 mM (for ECD spectra see SFigure 8). The pinpointed pathways and formation rate looks similar [c(E5)=250µM 
& c(NaCl)= 50mM (black) and c(E5)=500µM & c(NaCl)= 25mM, (claret) and c(E5)=800µM & c(NaCl)= 12.5mM, 
(green) (pH=4.1 & stirring at T=37°C)].. 
 
Furthermore, the rate of amyloid formation was probed at a fixed protein concentration (e.g. 
cE5=400 µM) with increasing salt concentration (cNaCl: 0 mM, 12.5mM, 25mM, 50 mM) (Figure 7/b, 
SFigure 10). We found that both misfolding and nucleation occurs at a quasi-similar rate. However, 
during the elongation phase clear differences were detected as function of cNaCl. Stirring for three days 
(t= 76 h) the amyloid ratio was found higher if salt concentration was lower: [Amy]c(NaC)l=0mM =0.85, 
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[Amy]c(NaC)l=12.5mM =0.78, [Amy]c(NaC)l=25mM =0.63, [Amy]c(NaC)l=50mM =0.52. This finding, at first glance, could 
suggest that the easy way to avoid amyloid formation - at least for E5 - is to use a high salt 
concentration. However, as we only detect amyloids of limited size by ECD (those that remain part of the 
solution), it is more likely that the larger salt concentration speeds up amyloid maturation and thus, 
eliminates shorter amyloid fragments from the solution, an assumption more in line with the literature 
data. Moreover, at the salt concentration used here (< 100 mM) the beside the nature of the anion and 
cation,  specific ion-binding to the polypeptide chain was also shown to contribute to the rate of 
amyloidosis (Marek Biochemistry 2012, Buell Biophys J. 2013, Klement J. Mol. Biol. 2007). This could well 
be the case for E5 also: during MD simulations of the monomeric protein (both at pH=7 and pH=4.1 in 
0.15M NaCl solution) ~10% of the all ion-protein interactions involved the charged residues of the 
Glu14↔Arg21 salt bridge, which might contribute to the loosening of the hydrophobic core of E5 (SFigure 
11), influencing the ratio of the misfolded structures present.  
 
Temperature-dependence revisited 
The effect of temperature on the kinetics of amyloid formation was revisited by using the fine-
tuned conditions of amyloid formation (cE5=250 µM, cNaCl= 50 mM and pH=4.1) (Figure 7/C, SFigure 12). 
We found that the process is slower and incomplete both at 23°C and 47°C, compared to that of the 
physiological temperature (37°C). It seems that at a high temperature the increased thermal motion 
disfavors self-association: [Amy]47°C & 51h =0.34 << [Amy]37°C & 51h =0.86. At temperatures too low, the 
Brownian motion is significantly slower and thus fewer collisions occur and the misfolding propensity of 
E5 gets lower (see NMR data above): [Amy]23°C & 51h =0.12.  
 
Figure 7.: Amyloid formation completeness monitored by Far-UV ECD as function of the time A) different protein 
(black: 800 µM, claret: 400 µM) but same ion concentration (12.5 mM) B) same protein (400µM) and different ion 
concentration (black: 50mM, claret: 25mM green:12.5mM, blue: 0 mM) C) same protein (250µM) and the same ion 
concentration (50 mM) at different temperatures: T= 23 °C (claret), 37 °C (black) and 47 °C (green). 
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Verifying amyloidosis – NUV-CD measurements 
The amyloid transformation was monitored from the viewpoint of the Y8↔W11 aromatic 
interaction by acquiring NUV-ECD data. At pH=6 the characteristic positive band at 283nm (over the 
entire tested protein concentration range) is indicative of a shifted face-to-face π-π interaction between 
the two aromatic rings of the hydrophobic core of E5 (Figure 8/A). However, at pH=4.1 negative bands 
were detected in this spectral region (270< λ< 290 nm) (Figure 8/B) and assigned to an edge-to-face π-π 
interaction, signaling that misfolding of E5 concerns the relative re-orientation of the two aromatic rings 
of the core. However, as amyloid transformation proceeds, gradually these negative bands are reverted 
and positive bands similar to those measured for the folded state but at a slightly shifted position 
appear. As amyloid formation progresses these bands intensify: after 26 h band intensities are about 10 
times higher than those of the initial F-state (Θ~283nm: 4000→ 40000) (Figure 8/A and C). This side chain 
restructuring coincides with the backbone changing from an α- to -state. Thus, we propose, that the 
enhanced positive NUV-ECD bands between 270< λ< 290 nm arise from no longer a pairwise, 
intramolecular shifted face-to-face π-π interaction, but rather from the interstrand interaction of Tyr and 
Trp side-chains packed tighter in the supramolecular assembly of the amyloid phase. 
 
 
Figure 8. NUV-ECD (240-325nm) spectra reveals how conformers and interaction modes of Y8↔W11 aromatic 
residues change as function of the pH and time. At pH:4.1 (B) the π-π interaction profile changes as protein 
concentration increases (84< cE5 < 730 µM @ 25°C, cNaCl~0mM), while remains unchanged (A) at pH:6.0. (C) NUV-
ECD spectral shift signals the changing interaction mode of Y8 & W11 as function of the time (0<t <26 h) during 
amyloid formation (cE5=800µM, cNaCl= 12.5mM, pH=4.1, stirring at T=37°C).  
 
The nature of the misfolded states 
Amyloid formation proceeds at physiological temperature, but it can be quenched if cooled to 
4°C. Thus, a series of heteronuclear correlation spectra (1H-15N HSQC) were recorded at 4°C using 
samples retrieved at regular time intervals (every 30 minutes) during amyloid formation (Figure 9). The 
1H,15N-chemical shifts of all residues were calculated  
 
Δ(t)= √[(δH(t))2+(δN(t)/6,51)2]   equ 2.  
 
as function of the time (0<t<24 h). Residues of larger changes than the average chemical shift (Δ(tend)- 
Δ(t0)> 0.047 ppm) are those of the α-helix (E2, E3, V5, L7, I9, Q10, K13), signaling that amyloid formation 
affects this region. Residues of the helix were found to be the most temperature sensitive ones as well 
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(SFigure 2), indicating that this region is assailable as soon as the shielding efficacy of the Trp-cage fold 
against water gets reduced. This region (segment -R6LYIQWL12-  was also predicted to be the most 
amyloidogenic of the sequence by CamSol (Sormanni 2015). Therefore, we propose that the -helix itself 
is the seed of amylogenic nucleation. As its misfolding and transient unwinding allows the reorientation 
of the aromatic side chains di- and oligomers of the misfolded structures can form interacting through 
their exposed hydrophobic cores.  
 
Figure 9. A) The superimposed best 50 structures of E5. NHs of Glu2, Glu3, Val5, Leu7, Gln10, Lys13 and Ser25 
(highlighted red) shift the most during amyloid forming (STable 2). B) Selected 1H- 15N-HSQC resonances of E5 
shifting noticeably: Δ(tend)- Δ(t0)> 0.047 ppm. C) NH of Ser18 shifting none was used as a reference. D) The absolute 
intensity of the 1H- 15N-HSQC resonances decay with time, indicating the loss of monomers and shorter oligomeric 
assemblies.  
 
Table.1 Conformational measures introduced to signal the degree of misfolding of E5. Each measure type a critical 
value or critical interval was specified to characterize the divergent/misfolded population of the ominous E5[1E-
1,2E0,3E0,14E0] microstate.  
 
# measure type description of the measure 
critical value of the 
measure 
i d11W↔17P  the distance between Trp11 & Pro17 d11W↔17P > 5.7 Å 
ii d11W↔23P   the distance between Trp11 & Pro23 d11W↔23P > 4.7  Å   
iii d11W↔21R  distance between NH of Trp11 and CO of Arg21 d11W↔21R > 6.0  Å 
iv d14E↔21R  distance between donor of Arg21 and acceptor of Glu14  
v μ (°) 
the torsional angle between the main axis of the core α-
helix and of the polyPro of the C-terminal 
μ> 45° 
vi dY8↔W11   distance between Tyr8 & Trp11 dY8↔W11  > 7.0  Å 
vii α (°) the angle between the planes of the aromatic rings α> 70° 
viii θ (°) the elevation of the aromatic rings 
θ> 6.5° 
40°> θ> 50° 
80°> θ> 90° 
ix φ (°) the azimuthal angle of the aromatic rings φ> 320° 
15 
 
Amyloid formation is optimal at pH= 4.1, where the overall charge of E5 is near +2 (Figure 1-3) 
and thus, on average 3 out of the 4 Glu side-chains are protonated. To identify that protonation state 
which is the most likely to trigger misfolding, MD simulations were carried out. At pH=7 only one 
possible protonation motif, that of E5[1E-1,2E-1,3E-1,14E-1] exists, while at pH=4.1 as many as 4 
(E5[1E0,2E0,3E0,14E-1]; E5[1E0,2E0,3E-1,14E0]; E5[1E0,2E-1,3E0,14E0]; E5[1E-1,2E0,3E0,14E0]) different protonation 
patterns have to be considered, which we will refer to as microstates. Conformational descriptors were 
selected to measure the extent of misfolding (see Methods, Table 1 and Figure 10, SFigure 13).  
The simulations of four microstates provided equilibrium ensembles quite similar to that of the 
folded structure derived from NMR data: those of, E5 pH=4.1[1E0,2E0,3E0,14E-1], E5pH=4.1[1E0,2E0,3E-1,14E0] and 
E5pH=4.1[1E0,2E-1,3E0,14E0] belonging to pH=4.1 and the microstate belonging to pH=7.0. On the contrary, a 
single microstate, that of E5pH=4.1[1E-1,2E0,3E0,14E0] was significantly different from any of the above when 
descriptors i-ix were evaluated, this state shows strong resemblance to the loosened NMR structural 
ensemble measured at pH=4.1. We found that in case of E5pH=4.1[1E-1,2E0,3E0,14E0] both d11W↔17P, and 
d11W↔23P, distances are lengthened by 0.4 and 0.3 Å, respectively, and in some conformers the d11W↔21R 
distance shifted from 2.85 Å to 5.85 Å, indicating the appearance of less compact protein folds. 
Furthermore, as the distribution of μ gets wider, the -PPP24- segment twists more often with respect to 
the main axes of the α-helix. In parallel, dY8↔W11 increases by 0.9 Å. The relative orientation of the 
aromatic side-chains changes as well: measured θ° shows a more diverse distribution relative to the 
other microstates, while the values of a° and  ° slightly increase. Summing these changes up, we might 
say that E5pH=4.1[1E0,2E0,3E0,14E-1] protonation microstate has an enhanced backbone conformational 
freedom and a significantly rearranged hydrophobic core, with respect to all the others. The Trp-cage 
gets occasionally very unfolded, giving rise to unshielded aromatics and exposed backbone amide 
groups, ready for self-association and subsequent amyloid formation (SFigure 13), though these events 
are transient, and misfolding is temporary. However, it should be noted that MD simulations carried out 
here consider isolated molecules. The exposed aromatic and hydrophobic sidechains create a “sticky” 
interaction center for E5, quite as the free -edges that appear transiently on the surface of locally 
misfolded large, globular proteins and become initiators of aggregation. Thus, when collisions among 
similarly loosened conformers of E5 are also considered, the described changes might become sufficient 
to create the first di- and oligomer nuclei of aggregates (Figure 13/A). These findings also explain why 
stirring is necessary for amyloid formation of E5 – since only one of the four possible protonation 
patterns of pH=4.1 produces a “misfolded enough” conformer, a great number of collisions are required 
for successful nucleation.  
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Figure 10. The distributions of conformational measures introduced to signal the degree of misfolding of E5.  
A-D The distribution of the selected measures for the MD trajectories  (grey – pH7, E5[1E-1,2E-1,3E-1,14E-1] ; orange – 
pH4 E5[1E0,2E0,3E0,14E-1] ; light blue – pH4 E5[1E0,2E0,3E-1,14E0]; yellow – pH4 E5[1E0,2E-1,3E0,14E0]; blue – pH4 E5[1E-
1,2E0,3E0,14E0]  are plotted, while the distribution of the selected measures for NMR structures (green – pH7, purple – 
pH4) are indicated for every single structures above the MD distribution curves in a linear 1D manner. The measures 
of E5[1E-1,2E0,3E0,14E0] microstate is slightly different from the other microstates, moreover a minor population of 
E5[1E-1,2E0,3E0,14E0] microstate show considerably distinct properties. Table 1 contains a limit for each measure that 
can be used to distinguish/separate the divergent/misfolded population of E5[1E-1,2E0,3E0,14E0] microstate. E) NMR 
calculated folded structure (grey) and F) one of the MD-based misfolded (blue) structures are shown to visualize the 
conformational differences. Additional distributions of the selected measures are shown in SFigure 14. 
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Building a model of the amyloid state 
 
To obtain a picture of the amyloid state, MD simulations were carried out for models of four β-
strand-clusters (E5)4 using three different protonation motifs: (E5pH=2[1E0,2E0,3E0,14E0, C-term0])4, 
(E5pH=4.1[1E-1,2E0,3E0,14E0])4 and (E5pH=7[1E-1,2E-1,3E-1,14E-1])4. (Four-stranded models were shown sufficiently 
large for modeling aggregation nuclei in various different systems ([Weihua Zheng 2017, Ngo 2017, 
Knowles 2014).) We have probed three different relative β-strand offsets, namely that of “YI”, “YK” and 
“YW”  (Figure 11/A, B and C) for each.  
 
Figure 11. A-C) The three different β-strand offsets of (E5)4 used for MD simulations. In each of the composed 
models, the central helix was extended and Tyr8 was paired antiparallel either with Ile9, Trp11 or Lys13 residues of 
the adjacent β-strand. D) The most populated amyloid-like tetramer cluster of YW (pH=4.1 between 100-340 ns) 
have shifted face-to-face π-π aromatic ring orientations (with ring separations of ~6 Å). On the contrary, neither YI, 
nor YK offsets made stable enough tetramers. E) The Ramachandran plot of the most populated cluster of the (E5)4 
YW structure with residues mainly located in the β-valley.  
From the three probed offsets YW turned out to be both the most stable at pH=4.1 and the most 
sensitive to pH shift (since both at pH=2 and 7, the folded conformation is most stable and practically no 
amyloid formation could be detected, we expected the most realistic model to be significantly more 
stable at pH=4.1) (SFigure 15). Considering that in the -PPP24- segment φPro must be ~-60° and thus this 
part of the sequence is unlikely to form an extended β-sheet structure (with φ~-145°, ψ~+145°), in case 
of the YW offset 18 pairs of interstrand H-bonds could be formed between residue 1-18 in total. In 
YWpH=4.1 on average 10 out of 18 H-bonds are present during the MD simulation between the two middle 
chains typically involving residue-pairs such as V5-E14, L7-L12, I9-Q10, W11-Y8, and K13-R6. These interstrand 
H-bonds confirm that an aggregation core can indeed form between residues 5-14, as suggested above. 
Furthermore, in this arrangement of YWpH=4.1 an aromatic ladder forms between the Y8 and W11 side-
chains of adjacent β-strands, as they come in close proximity (dY8↔W11 <6 Å as measured between the 
center of the rings) (Figure 11/D). In addition, the aromatic ladder enables the formation of the shifted 
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face-to-face π-π interaction expected based on ECD spectroscopic data. Interestingly, the derived 
orientation and spacing of the Tyr and Trp sidechains here is also quite reminiscent of the aromatic 
clusters created by mutations within the central single-layer β-sheet of Borrelia outer surface protein A 
(OspA) to probe the structure-ordering capacity of such residues [Biancalana, 2015. Prot. Sci]. 
Using the mid-structures of six different clusters (see methods) of the MD simulation of (E5pH=4.1)4_YW as 
possible amyloid seeds, we probed different inter-sheet arrangements as well, by using a protein-protein 
docking algorithm. The near-parallel arrangements thus obtained could be grouped into two basically 
different topologies (using the nomenclature introduced by Eisenberg and coworkers [Eisenberg 2016 
Annu. Rev. Biochem]): those of class 7 (equifacial, antisymmetric, up-up) with translational symmetry 
and class 8 (antiparallel, equifacial, antisymmetric, up-down) with 2-fold symmetry (Figure 12). In the 
derived β-sheet-dimers, ((E5pH=4.1)4)2, the average distance between the β-sheets separated by the zipper 
interface varies between 10-12 Å, in line with the 8-10 Å experimental values determined for various 
amyloid structures [Berhanu 2012. PLoS One][Xi 2016. Chin. Phys B.] [Colletier 2011. 
Proc.Natl.Acad.Sci.USA][Soriaga 2016. J.Phys.Chem.B][Saelices 2018. Protein Sci.]. Furthermore, in this 
sandwich form, the intersheet aromatic sidechains may approach each other even closer than the 
intrasheet 6 Å described above (Figure 13/B). We found that (E5pH=4.1)4 seeds with a slightly twisted 
backbone find partners more readily to form the sandwich structure than those with fully extended 
backbones, in accordance with the general view that twisted filaments are more stable and thus more 
prevalent in nature [Lu 2018. J. Phys. Chem. B]. These findings further support our model for the 
aggregation of E5 as nucleated by the antiparallel oriented β-sheets formed between the most 
aggregation-prone segment of the sequence, the -V5RLYIQWLK13- unit. 
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Figure 12. The two basic topologies found by docking (E5)4 amyloid seeds are the antiparallel equifacial 
antisymmetric up-down (class8) with a 2 fold symmetry and equifacial antisymmetric up-up (class7) with 
translational symmetry. The schematic illustrations of the basic amyloid layout shown have the aromatic residues 
highlighted: above, Tyr: light blue triangle and Trp: dark blue circle. Twisted amyloid β-sheets (below) and 90° 
rotated plus enlarged view of the aromatic residues are shown in the middle: Tyr (light blue) and Trp (dark blue) 
with oxygen atoms red and nitrogen middle blue). Red double arrows show the specific distance of the associated β-
sheets.  
 
Figure 13. A: Possible self-aligning mode of a conformer of the MD simulation. The antiparallel orientation of the 
helices is due to coulombic interactions operative at pH=4.1 in the selected microstate. Aromatic-aromatic (Y-W) 
interaction driven backbone pairing of the misfolded molecules. B: Schematic illustration of a hypothetic late phase 
intersheet orientation of the aromatic rings (Tyr: light blue, Trp: dark blue). The intrasheet distance between the 
center of masses of the two aromatic sidechains is 5-6 Å (yellow double arrows), while possible intersheet aromatic-
aromatic distance can be 3-4 Å (red double arrows), while the sheet-sheet distance is 10-12 Å (blue double arrow). 
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Conclusion 
Concerning E5, the Exenatide variant studied here, we found that its amyloid aggregation is most 
likely triggered by the transiently exposed aromatic and hydrophobic side-chains of loosened – misfolded 
- conformers, which create a center for intermolecular associations. The clusters thus created provide 
stabilization (spatial closeness for sufficient time) for the much slower process of -helix to the coil and 
then to an extended -strand transition, which seems to be highly unfavorable for the monomeric forms 
but eventually leads to the formation of a β-structured amyloid nucleus. The amyloidosis of E5 thus 
follows the nucleated growth mechanism described elsewhere (C-C. Lee et al. Biophys. J. 2007, Serio, T. 
R. Science. 2000).  
Studying the early phases of amyloid formation is crucially important both for understanding the 
initialization of various pathophysiological processes and for aiding the design of non-toxic peptide 
medications that will not become initiators of such processes themselves. We derived a new monitoring 
technique of amyloid progression that can be applied even if the amyloid in question is ThT silent - using 
simple ECD measurements. Decomposition of the spectra and its barycentric representation on the 
folded-unfolded-amyloid potential energy surface pinpointing the pathway of the amyloidic transition 
can be applied to filter out potentially harmful sequences from development. Generally, it can be 
concluded that the lowest possible salt concentration, low temperatures and the absence of agitation 
can prolong the shelf-life of any polypeptide and protein medications, but somewhat disturbingly we 
also found that the optimum temperature for E5 amyloidosis coincides with our body temperature and 
requires well below physiological salt concentration. This just underlines how important it is to test the 
aggregation propensity of any drug candidates. 
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Methods  
Protein expression and purification: The E5 miniprotein was produced by bacterial expression using the 
previously published protocol. ref: Stráner, P., Taricska, N., Szabó, M., Tóth, K. G., Perczel, A. Bacterial 
expression and/or solid phase peptide synthesis of 20-40 amino acid long polypeptides and miniproteins, 
the case study of Class B GPCR ligands. Current Protein and Peptide Science 17, 147-155 (2016). 
 
Preparation of amyloid form of E5 miniprotein: The lyophilized E5 samples were dissolved in distilled 
water. First, the pH of protein solution was adjusted to pH=7 with 0.1 M NaOH solution (Orion Star A211 
pH meter (Thermo Scientific™)) then decreased to 4.1 or lower (pH-dependent amyloid formation) with 
0.1 M HCl solution. Finally desired NaCl concentration was adjusted with concentrated NaCl solution. The 
protein solution was stirred (with magnetic stirrer rpm) and incubated at target temperatures. At a given 
time 10 fold diluted sample was measured with ECD spectroscopy. The concentration of every diluted 
sample was determined by NanoDrop Lite Spectrophotometer (Thermo Scientific™) at 280 nm. 
 
NMR experiments:  Datasets were collected on a 16.4 T Bruker Avance III spectrometer equipped with a 
5 mm inverse TCI probe-head with z-gradient. Each sample contained 700-900 μM of E5 peptide, 10% 
D2O, 0.1 mM NaN3 and DSS as an internal proton reference standard. The concentrations were 
determined by Nanodrop. The sample pH was set between pH 7.1 and 2.0 by using 0.1M NaCl or HCl and 
the measurements were recorded from 277.0 K to 321K by equal steps of 11 K. Spinlock (d9) for 1H–1H 
TOCSY was 80ms, while the mixing time (d8) of 150 ms was taken for 1H–1H NOESY spectra.  Raw 
spectra were processed by TopSpin 3.2 and the homonuclear proton NMR assignations were made using 
CcpNmr Analysis 2.4.1. (Vranken; 2005; Proteins) The NMR structure calculations were performed and 
refined by cooperative use of CcpNmr Analysis 2.4.1., Aria 2.0 (Rieping; 2007; Bioinformatic)  and CNS 
Solve 1.2. (Brunger,2007;Nature Protocols)  The NOE cross-peak intensities were converted into 
distance. The peak volume scaling factor is defined such that the peak list’s average volume corresponds 
to the default 3.2 Angstroms. Each ensemble was refined in water and contains 50 structures.  
Molecular dynamics simulations: MD simulation were carried out as implemented in GROMACS59, using 
the AMBER-ff99SBildnp* forcefield. The systems were solvated with TIP3P water molecules in 
dodecahedral boxes with a size allowing 10Å between any protein atom and the box. The total charge 
was neutralized and physiological salt concentration was set using Na+ and Cl- ions. Energy minimization 
of starting structures was followed by sequential relaxation of constraints on protein atoms in three 
steps and an additional NVT step (100 ps) to stabilize pressure. Trajectories of 600 ((E5)4 models) -1000ns 
(E5 monomers) NPT simulations with a 2fs time step at 310K and 328K and 1bar were collected (with 
snapshots at every 4ps).  The last 500ns of the trajectories were clustered fitting the main-chain atoms 
using a 1Å cutoff in case of the monomers, while the last 400ns of the trajectories of the tetramer sheets 
were clustered using a 1.7 Å cutoff fitting the main-chain atoms of the seed segment (residues 6-13). 112 
clusters were found (95% of the snapshots are in 32 clusters). For docking 4-stranded seed models to 
one-another, we choose six different 4-stranded sheet conformer (middle structures of six different 
clusters from the MD simulation of the (E5pH=4.1[1E-1,2E0,3E0,14E0])4 microstate with an YW offset) which 
were docked to another identical 4-stranded sheet, using Piper [Kozakov, 2006, Proteins]During docking 
the sidechains were rigid, 10000 ligand rotations were probed and the 30 largest clusters were chosen 
for further analysis. We selected manually the most relevant amyloid-like structures from the clusters 
(less than 45° angle between the strands, the plane of the sheets close to parallel): these were 10-24% of 
the total 30 clusters. The distance of the β-sheets was measured as the backbone distance the aromatic 
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residues of the two middle chains between the two opposite sheets of the amyloid seed region (residues 
6-13).  
Electronic circular dichroism spectroscopy: Far and near-UV ECD measurements were carried out on a 
Jasco J810 spectrophotometer in 1.0 and 10 mm quartz cuvettes. Typically we used spectral scanning 
speed of  50 nm/min with 1 nm bandwidth and the 0.2 nm step resolution over wavelength range 185-
260 nm (far-UV) and 240-325 nm (near-UV) with three and four scans averaged for each spectrum. The 
temperature at the cuvette was controlled by Peltier-type heating system (temperature dependent 
measurements were made from 5°C to 85°C in 5°C steps and the amyloid samples were measured at 
25°C). The raw ellipticity data were converted into mean residue molar ellipticity units ([θ]MR/ 
deg*cm2*dmol-1) for the far-UV region and molar ellipticity ([θ]/ deg*cm2*dmol-1) for the near-UV 
region. 
 
CCA+ deconvolution: During deconvolution of amyloid formation we used the temperature dependent 
ECD spectra of E5 (as folded) and E0 (as unfolded) miniprotein. (These spectra were measured from 5°C 
to 85°C for 5°C step (17 spectra/ miniprotein)). This resulting matrix was deconvoluted into 3 
components and then reported in a barycentric coordinate system.  
 
TEM measurement: Sample solution (5 L) was spotted onto a collodion-coated copper grid (Nisshin EM 
Co., Tokyo, Japan). After 1 min, the remaining solution was removed with filter paper and 5 L of 2 % 
(w/v) ammonium molybdate was spotted onto the grids. After 1 min, the remaining solution was 
removed in the same manner. TEM images were obtained with a Hitachi H-7650 transmission electron 
microscope (Tokyo, Japan) with a voltage of 80 kV.   
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